Abstract:
:Acute attacks of multiple sclerosis (MS) are most commonly treated with glucocorticoids, which can provide life-saving albeit only temporary symptomatic relief. The mechanism of action (MOA) is now known to involve induction of indoleamine 2,3-dioxygenase (IDO) and interleukin-10 (IL-10), where IL-10 requires subsequent heme oxygenase-1 (HMOX-1) induction. Ectopic expression studies reveal that even small changes in expression of IDO, HMOX-1, or mitochondrial superoxide dismutase (SOD2) can prevent demyelination in experimental autoimmune encephalomyelitis (EAE) animal models of MS. An alternative to glucocorticoids is needed for a long-term treatment of MS. A distinctly short list of endogenous activators of both membrane G-protein-coupled receptors and nuclear peroxisome proliferating antigen receptors (PPARs) demonstrably ameliorate EAE pathogenesis by MOAs resembling that of glucocorticoids. These dual activators and potential MS therapeutics include endocannabinoids and the prostaglandin 15-deoxy-Δ¹²,¹⁴-PGJ₂. Nicotinamide profoundly ameliorates and prevents autoimmune-mediated demyelination in EAE via maintaining levels of nicotinamide adenine dinucleotide (NAD), without activating PPAR nor any G-protein-coupled receptor. By comparison, nicotinic acid provides even greater levels of NAD than nicotinamide in many tissues, while additionally activating the PPARγ-dependent pathway already shown to provide relief in animal models of MS after activation of GPR109a/HM74a. Thus nicotinic acid is uniquely suited for providing therapeutic relief in MS. However nicotinic acid is unexamined in MS research. Nicotinic acid penetrates the blood brain barrier, cures pellagric dementia, has been used for over 50 years clinically without toxicity, and raises HDL concentrations to a greater degree than any pharmaceutical, thus providing unparalleled benefits against lipodystrophy. Summary analysis reveals that the expected therapeutic benefits of high-dose nicotinic acid administration far outweigh any known adverse risks in consideration for the treatment of multiple sclerosis.
journal_name
PPAR Resjournal_title
PPAR researchauthors
Penberthy WTdoi
10.1155/2009/853707subject
Has Abstractpub_date
2009-01-01 00:00:00pages
853707eissn
1687-4757issn
1687-4765journal_volume
2009pub_type
杂志文章相关文献
PPAR Research文献大全abstract::Hyperhomocysteinemia, a risk factor for vascular disease, is associated with metabolic syndrome. Our study was aimed at exploring the effect of long-term hyperhomocysteinemia with metabolic disturbances on vascular remodeling. We also studied oxidative stress and expression of PPARγ in the coronary arteriole as a poss...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2018/6738703
更新日期:2018-01-15 00:00:00
abstract::Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptional regulation of g...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/461981
更新日期:2008-01-01 00:00:00
abstract::Improvements in our understanding of the functions of the nuclear receptor peroxisome proliferator-activated receptor (PPAR) subtypes as pleiotropic regulators of biological responses, including lipid, lipoprotein, glucose homeostasis, inflammation, differentiation and proliferation of various cancer cells, and memory...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/689859
更新日期:2008-01-01 00:00:00
abstract::Peroxisome proliferator-activated receptor γ (PPARγ) forms a heterodimeric DNA-binding complex with retinoid X receptors (RXRs). It has been reported that the effect of the PPAR agonist is reduced in hepatocyte RXR-deficient mice. Therefore, it is suggested that the endogenous RXR ligand is involved in the PPARγ agoni...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2011/840194
更新日期:2011-01-01 00:00:00
abstract::Colorectal cancer is one of the most common cancers in the world. Dietary fat intake is a major risk factor for colorectal cancer. Some nuclear hormone receptors play an important role in regulating nutrient metabolism and energy homeostasis. Among these receptors, special attention has been focused on the role of per...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2012/876418
更新日期:2012-01-01 00:00:00
abstract::Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of the women of reproductive age. Familial clustering of PCOS has been consistently reported suggesting that genetic factors play a role in the development of the syndrome although PCOS cases do not exhibit a clear pattern of Mendelian inheritance....
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2007/49109
更新日期:2007-01-01 00:00:00
abstract::Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor (NR) superfamily of ligand-activated transcriptional factors. Among other functions, PPAR-gamma acts as a key regulator of the adipogenesis. Since several cytokines (IL-1, TNF-alpha, TGF-beta) had been known to inhibit ad...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2010/341671
更新日期:2010-01-01 00:00:00
abstract::During pregnancy crucial anatomic, physiologic, and metabolic changes challenge the mother and the fetus. The placenta is a remarkable organ that allows the mother and the fetus to adapt to the new metabolic, immunologic, and angiogenic environment imposed by gestation. One of the physiologic systems that appears to h...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/527048
更新日期:2008-01-01 00:00:00
abstract::Dysfunction of macro- and microvessels is a major cause of morbidity and mortality in patients with cardio-renovascular diseases such as atherosclerosis, hypertension, and diabetes. Renal failure and impairment of renal function due to vasoconstriction of the glomerular arteriole in diabetic nephropathy leads to renal...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2010/806538
更新日期:2010-01-01 00:00:00
abstract::PPAR isotypes are involved in the regulation of cell proliferation, death, and differentiation, with different roles and mechanisms depending on the specific isotype and ligand and on the differentiated, undifferentiated, or transformed status of the cell. Differentiation stimuli are integrated by key transcription fa...
journal_title:PPAR research
pub_type: 杂志文章,收录出版
doi:10.1155/2007/48242
更新日期:2007-01-01 00:00:00
abstract::INT131 (formerly T0903131, T131, AMG131) is a potent non-thiazolidinedione (TZD) selective peroxisome proliferator-activated receptor gamma modulator (SPPARM) currently in Phase 2 clinical trials for treatment of type-2 diabetes mellitus (T2DM). This new chemical entity represents a second generation SPPARM approach d...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/936906
更新日期:2008-01-01 00:00:00
abstract::Dendritic cells (DCs) can regulate all elements of the immune system, and therefore are an ideal target for vaccination. During the last two decades, as a result of extensive research, DCs became the primary target of antitumor vaccination as well. A critical issue of antitumor vaccination is the phenotype of the dend...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/473804
更新日期:2008-01-01 00:00:00
abstract::PPARγ agonists can either enhance or inhibit eosinophil migration, which is a sum of directional migration (chemotaxis) and random cell movement (chemokinesis). To date, the effects of PPAR agonists on chemokinesis have not been examined. This study investigates the effects of PPARα, δ, and γ agonists on eosinophil mi...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2012/235231
更新日期:2012-01-01 00:00:00
abstract::The PPAR nuclear receptor family has acquired great relevance in the last decade, which is formed by three different isoforms (PPARα, PPARβ/δ, and PPAR ϒ). Those nuclear receptors are members of the steroid receptor superfamily which take part in essential metabolic and life-sustaining actions. Specifically, PPARG has...
journal_title:PPAR research
pub_type: 杂志文章,评审
doi:10.1155/2016/2308249
更新日期:2016-01-01 00:00:00
abstract::Aster glehni is well known for its therapeutic properties. This study was performed to investigate the effects of A. glehni on nonalcoholic fatty liver disease (NAFLD) in atherosclerotic condition, by determining the levels of biomarkers related to lipid metabolism and inflammation in serum, liver, and adipose tissue....
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2017/3912567
更新日期:2017-01-01 00:00:00
abstract::While TOFA (acetyl CoA carboxylase inhibitor) and C75 (fatty acid synthase inhibitor) prevent lipid accumulation by inhibiting fatty acid synthesis, the mechanism of action is not simply accounted for by inhibition of the enzymes alone. Liver fatty acid binding protein (L-FABP), a mediator of long chain fatty acid sig...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2013/865604
更新日期:2013-01-01 00:00:00
abstract::Nitrooleic acid (OA-NO2) is endogenous ligands for peroxisome proliferator-activated receptors. The present study was aimed at investigating the beneficial effects of OA-NO2 on the lipid metabolism and liver steatosis in deoxycorticosterone acetate- (DOCA-) salt induced hypertensive mice model. Male C57BL/6 mice were ...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2015/480348
更新日期:2015-01-01 00:00:00
abstract::Foxp3(+) regulatory T cells (Tregs) play a critical role in maintaining immune self-tolerance. Reduced number and activity of Tregs are usually found in autoimmune and inflammatory diseases, and enhancing the differentiation of Tregs may be a promising therapeutic strategy. Some reports suggested an anti-inflammatory ...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2012/529035
更新日期:2012-01-01 00:00:00
abstract::To investigate the effects of fimasartan on nonalcoholic fatty liver disease in hyperlipidemic and hypertensive conditions, the levels of biomarkers related to fatty acid metabolism were determined in HepG2 and differentiated 3T3-L1 cells treated by high fatty acid and liver and visceral fat tissue samples of spontane...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2017/8048720
更新日期:2017-01-01 00:00:00
abstract::PPARs are ligand-activated transcriptional factors that belong to the nuclear receptor superfamily. Among them, PPAR alpha and PPAR gamma are prone to exert an antiangiogenic effect, whereas PPAR beta/delta has an opposite effect in physiological and pathological conditions. Angiogenesis has been known as a hallmark o...
journal_title:PPAR research
pub_type: 杂志文章,评审
doi:10.1155/2020/3608315
更新日期:2020-08-13 00:00:00
abstract::The Peroxisome Proliferator-Activated Receptors (PPARs) PPARA and PPARD are regulators of lipid metabolism with important roles in energy release through lipid breakdown, while PPARG plays a key role in lipid storage and adipogenesis. The aim of this review is to describe the role of PPARs in lipid metabolism, adipoge...
journal_title:PPAR research
pub_type: 杂志文章,评审
doi:10.1155/2015/358029
更新日期:2015-01-01 00:00:00
abstract::Peroxisome proliferators activated receptors (PPARs) are ligand-activated nuclear transcription factors that play important roles in lipid and glucose homeostasis. To the extent that PPAR agonists improve diabetic dyslipidaemia and insulin resistance, these agents have been considered to reduce cardiovascular risk. Ho...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/245410
更新日期:2008-01-01 00:00:00
abstract::The upregulation of peroxisome proliferator-activated receptor gamma (PPARG) has been shown to increase the chemosensitivity of several human cancers. This study is aimed at studying if PPARG sensitizes hypopharyngeal squamous cell carcinoma (HSCC) in chemotherapeutic treatments and at dissecting possible mechanisms o...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2020/6452182
更新日期:2020-04-22 00:00:00
abstract::The peroxisome proliferator-activated receptors (PPARs), which are ligand-inducible transcription factors expressed in a variety of tissues, have been shown to perform key roles in lipid homeostasis. In physiological situations such as fasting and physical exercise, one PPAR subtype, PPARdelta, triggers a transcriptio...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/172676
更新日期:2008-01-01 00:00:00
abstract::Peroxisome proliferator-activated receptor-gamma (PPARgamma), one of three ligand-activated transcription factors named PPAR, has been identified as a molecular target for cancer chemopreventive agents. PPARgamma was initially understood as a regulator of adipocyte differentiation and glucose homeostasis while later o...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/436489
更新日期:2008-01-01 00:00:00
abstract::The peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist rosiglitazone inhibits NF-κB expression and endogenous neural stem cell differentiation into neurons and reduces the inflammatory cascade after spinal cord injury (SCI). The aim of this study was to explore the mechanisms underlying rosiglitazone-me...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2018/3897478
更新日期:2018-06-21 00:00:00
abstract::Peroxisome proliferator-activated receptors (PPAR alpha, beta/delta and gamma) play a key role in metabolic regulatory processes and gene regulation of cellular metabolism, particularly in the cardiovascular system. Moreover, PPARs have various extra metabolic roles, in circadian rhythms, inflammation and oxidative st...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2010/783273
更新日期:2010-01-01 00:00:00
abstract::Glioblastoma multiforme (GBM) represents one of the most frequent malignant brain tumors. Current therapies do not provide real solutions to this pathology. Their failure can be ascribed to a cell subpopulation with stem-like properties called glioma stem cells (GSCs). Therefore, new therapeutic strategies GSC-targete...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2016/7175067
更新日期:2016-01-01 00:00:00
abstract::Cells can shift their metabolism between glycolysis and oxidative phosphorylation to enact their cell fate program in response to external signals. Widely distributed α1-adrenergic receptors (ARs) are physiologically stimulated during exercise, were reported to associate with the activating energetic AMPK pathway, and...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2020/3785137
更新日期:2020-02-01 00:00:00
abstract::Pancreatic cancer is a devastating disease in which current therapies are inadequate. Separate lines of research have identified the 5-lipoxygenase/leukotriene B(4) receptor pathway and the PPARgamma pathway as potential targets for prevention or treatment of this disease. LY293111 was originally designed as a potent ...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/827096
更新日期:2008-01-01 00:00:00